ACB
ACB
NASDAQ · Pharmaceuticals

Aurora Cannabis Inc

$3.41
-0.02 (-0.58%)
As of May 9, 9:43 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +493.0% upside
Low Target $15.45
Average Target $20.22
High Target $24.58
Current Price $3.41
Current
$3.41
Target
$20.22
$15.45 $20.22 avg $24.58
Scenario Analysis
Bear Case
$15.45
353.1%
Low target
Base Case
$20.22
+493.0%
Avg target
Bull Case
$24.58
+620.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.33
-63.5% from high
52-Week Low
$4.29
+-20.4% from low
Target vs 52W High
$20.22
+116.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%